Volume 27, Issue 10 (1-2020)                   JSSU 2020, 27(10): 1941-1952 | Back to browse issues page


XML Persian Abstract Print


Abstract:   (2039 Views)
Introduction: The use of rehabilitation treatments along with drug therapy can greatly help in the treatment of schizophrenic patients and their return to society. The purpose of this study was to evaluate the effectiveness of the Community Re-entry Program on improving insight in people with schizophrenia.
Methods: The present study is a pre-test, post-test clinical trial with the statistical population including all patients with schizophrenia admitted to the Tolue rehabilitation center. For this purpose, 40 patients admitted to Tolue Rehabilitation Center who met the inclusion criteria were selected by convenience sampling method and were randomly assigned to experimental (n = 20) and control (n = 20) groups. The experimental group received a community Re-entry program for sixteen sessions. The groups were tested by Anderson's positive and negative symptoms questionnaire before and after the intervention, after completion and two months later. Data were analyzed using t-test for two independent groups, and covariance analysis by SPSS Inc., Chicago, IL; Version 18 
Results: The results showed that patients in experimental group compared to control group after implementation of community Re-entry program on negative symptom scales (P = 0.000), disruption (P = 0.000), excitement (P = 0.000)). Anxiety, depression (P = 0.000), positive symptoms (P = 0.000) and total positive and negative symptoms (P = 0.000) at posttest and follow-up on negative symptom scales (P = 0.000). Significant differences were observed between rupture (P = 0.000), excitement (P = 0.01), anxiety and depression (P = 0.000), positive symptoms (P = 0.000) and total positive and negative symptoms (P = 0.001). (P-value<0/05).
Full-Text [PDF 263 kb]   (593 Downloads)    
Type of Study: Original article | Subject: Psychology
Received: 2019/05/31 | Accepted: 2019/08/10 | Published: 2020/02/22

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.